Objective To identify associations between demographic, disease-related and psychological variables and severe distress from pelvic floor symptoms (PFS) following cervical cancer treatment. Methods This study was cross-sectional and questionnaire-based. We included cervical cancer patients treated between 1997 and 2007 in the Academic Medical Center, Amsterdam. PFS were assessed with Uro-Genital Distress Inventory (UDI) and Defecatory Distress Inventory (DDI). Scores were dichotomized into severe (>90 th percentile)
Introduction
Cervical cancer has a good prognosis resulting in a five-year survival rate of 70 -85% in patients with International Federation of Obstetrics and Gynecology (FIGO) stage IBI -IIA. (1) In more advanced stages the 5-year-survival rate is lower, e.g. for FIGO stage IB2 -IIB it ranges between 50 and 70% and for FIGO stages III -IV between 5 -50%.
(1) Unfortunately, cervical cancer treatment is associated with long-term adverse effects on pelvic floor function.(2;3) Pelvic floor symptoms, such as overactive bladder, urinary or fecal incontinence are known to decrease quality of life. (4) (5) (6) (7) (8) Radical surgical treatment of cervical cancer is especially known for its effects on bladder function which result in difficulty to empty the bladder, so-called obstructive voiding symptoms, and incontinence symptoms.(2;9) Radiotherapy of the pelvis is also known for its adverse effects on bladder and bowel function, such as overactive bladder symptoms and anal incontinence.(3;9) It is, however, not clear whether the different treatment modalities are the only variables associated with severe distress from pelvic floor symptoms in the long term. Possible other associated factors include demographic variables, such as age and parity, as these variables appear to be related to the perceived severity of pelvic floor symptoms in healthy women. (10) (11) (12) It is likely that disease-related variables, such as tumor diameter and stage of disease, directly and indirectly affect pelvic organ function. Directly, as larger tumors may infiltrate more into surrounding nerves, impairing more severely function of the innervated organs than smaller tumors. And indirectly, as more extensive treatment is needed for larger tumors, and more radical surgery and higher dosage radiotherapy are known to cause more side effects. Finally, patients' psychosocial characteristics may affect the impact that pelvic floor symptoms have on the quality of life. Impaired general quality of life is associated with distress from pelvic floor function.(13) Body image and a low level of optimism have been found to influence health-related quality of life in cervical cancer patients after treatment. (13;14) ; (15;16) Insight into variables associated with severe distress from pelvic floor symptoms after cervical cancer treatment, could improve counseling and alert treating physicians to modifiable factors. It has been shown that patients treated for gynecological malignancies appreciate more attention to diagnosis and treatment of their pelvic floor symptoms after treatment. (17) This study aimed to identify associations between severe distress from pelvic floor symptoms after cervical cancer treatment and demographic, disease-related, and psychological variables.
Methods
A cross-sectional study was performed in the Academic Medical Center Amsterdam (AMC), The Netherlands. The local Medical Ethical Committee approved the protocol. We identified all women treated for cervical cancer between 1997 and 2007 in the AMC. Eligibility criteria were: adequate knowledge of the Dutch language, capability to understand and complete a questionnaire, no previous surgical removal of the bladder and / or recto-sigmoid and not being treated for recurrent or progression of malignant disease during the 12 months prior to start of the study. The treating gynecological oncologists informed their own patients who met the inclusion criteria about the study. Patients, who gave no notification of unwillingness to participate, were sent a set of questionnaires. As each treatment modality was found to have impact on the type of post-treatment pelvic floor symptoms, we divided the study population into 3 groups: patients treated with [1] radical hysterectomy and pelvic lymph node dissection according to the WertheimOkabayashi procedure (RH+LND) (18) , [2] surgery and adjuvant radiotherapy (SART) or [3] primary radiotherapy (PRT). This study group has been partly included, i.e. patients aged between 20 and 70 years, in a previous study. (9) Distress from pelvic floor symptoms was assessed by the Dutch validated Uro-genital Distress Inventory (UDI) and the Defecatory Distress Inventory (DDI). (19;20) These questionnaires assess the presence and experienced distress (rated on a four-point Likert scale, ranging from 'not at all' to 'greatly') of micturition and defecation symptoms. The responses can be translated to 5 domain scores per questionnaire. We excluded the prolapse domains as these symptoms are seldom prevalent in cervical cancer patients. Each domain score ranges from 0 to 100 and a higher score corresponds to more distress of pelvic floor symptoms. We defined severe distress related to pelvic floor symptoms as a score at or above the 90 th percentile of the domain score in the general female population. This appeared to be an appropriate cut-off score in a study of age-and paritymatched cervical cancer patients and females from the general population. (24) Higher scores correspond to more optimism. For assessing body image we used the Body Image Scale (BIS); a higher score indicating more disturbance. (25) Statistical analysis We dichotomized the symptom domain scores into severe and non-severe distress with the cut-off point at the 90 th percentile of domain scores of a random female population, as done in our previous study. (9) To reduce the number of statistical tests, we divided the symptoms in severe urogenital and severe defecation symptoms. If patients had severe distress in one or more domains of the UDI or DDI they were assigned to the respectively severe urogenital or defecation symptoms group. Logistic regression was performed to identify which variable was significantly associated to severe distress of urogenital or defecation symptoms. We imputed missing data with the multiple-imputation method for outcome measures of which 10% or less of the data were missing. (26) For all categorical variables, i.e. FIGO stage and tumor diameter, a contrast coding was used with the lowest value as indicator. Variables that reached a significance level of 15% in the univariate logistic regression analysis were included in the multivariate analysis for which a significance level of 5% was employed. The SPSS program version 16.0.2 was used for statistical analyses.
Results
Between 1997 and 2007, 982 women were treated in the AMC because of cervical cancer, of whom 498 were eligible for this study. We sent a set of questionnaires to these patients, of whom 332 (67%) responded. 282 patients had been treated according to the selected treatment modalities whose data were used for analyses. Table 1 shows the results of the demographic, disease-related and psychosocial variables of the patients per treatment group. The demographic variables show that the RH+LND group was younger, more often nulliparous, more often higher educated and more often a smoker in comparison to the other two groups. As expected, the disease related variables varied between the RH+LND, SART and PRT treatment groups. For example, 99%, 93% and 42% of respectively RH+LND, SART and PRT patients had early stage cervical cancer, i.e. FIGO stages IA -IIA. The highest median scores for mental well-being, physical function and optimism were found in the RH+LND group. The lowest median score for body image, indicating little body image disturbance, was reported by the PRT group. Table 2 displays the number and percentage of patients per treatment group who reported severe distress from pelvic floor symptoms. Severe distress from urinary incontinence and obstructive voiding was reported by 24 to 36% of patients across treatment groups. In addition, 26% and 35% of respectively SART and PRT patients reported severe distress from overactive bladder symptoms. In patients treated with PRT, 35% reported severe distress related to anal incontinence. Of RH+LND patients 71 (48%) had a score above the cut-off value for one or more domain score(s) and was therefore considered to have severe urogenital symptoms (UDI) and 39 (26%) patients reported severe defecation symptoms (DDI). Thirty SART patients (49%) reported severe urogenital symptoms and 23 (38%) severe defecation symptoms. Of the PRT patients 41 (56%) reported severe urogenital symptoms and 34 (47%) severe defecation symptoms.
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Associations PFS and cervical cancer treatment Legend: RH+LND: radical hysterectomy and pelvic lymph node dissection; SART: surgery and adjuvant radiotherapy; PRT: primary radiotherapy; MCS: Mental Component score, PCS: Physical Component score, both ranging from 0 -100, the higher the score the better rating of respectively mental and physical condition. LOT: Life Orientation Test, ranging from 0 to 32; higher scores correspond with more dispositional optimism. BIS: Body Image Scale, ranging from 0 to 30; a higher score reflects more distress about body image. * median (range) Legend: numbers (%) of patients per treatment group scoring above the 90th percentile of the UDI and DDI domain scores of a general female population sample (20) . RH+LND: radical hysterectomy and pelvic lymph node dissection; SART: Surgery and adjuvant radiotherapy; PRT: primary radiotherapy Tables 3a, b and c show the results of the univariate and multivariate logistic regression analysis for RH+LND, SART and PRT patients, respectively. In all treatment groups none of the demographic and disease-related variables were statistically significant after the multivariate regression analyses. In RH+LND patients better mental and physical well-being were related to non-severe urogenital and defecation symptoms. In SART patients no variables were associated with urogenital symptoms and better physical function with non-severe defecation symptoms. In PRT patients better physical well-being was multivariately associated with non-severe urogenital symptoms and increased body image disturbance with severe defecation symptoms.
Discussion
In this cross-sectional study, we identified associations between severe pelvic floor symptoms and demographic, disease-related and psychological variables in cervical cancer survivors. Of RH+LND and SART patients almost 50% reported severe urogenital symptoms. Of PRT patients even 56% reported severe urogenital symptoms and almost 50% reported severe defecation symptoms. No associations between demographic and disease related variables and severe pelvic floor symptoms were identified in the different treatment groups. Only better mental and physical function was related to non-severe pelvic floor symptoms and in PRT patients increased body image disturbance was related to severe defecation symptoms. Before interpreting the results, some limitations of this study need to be addressed. First, due to the observational study-design, conclusions about causal relations cannot be drawn. The results of this study provide hypotheses for future studies to unravel the causality of the observed associations. Second, the demographic variables were collected at the moment the patient completed the questionnaire and not prior to treatment. In addition, we do not have information about the individual status of pelvic floor function prior to cancer treatment. However, in a study of age and parity matched-patients and females from the general population, women were found to report more distress from pelvic floor symptoms after cervical cancer treatment, than their controls. Therefore age and parity at time of treatment is probably not of influence on the prevalence of severe pelvic floor symptoms after treatment. Finally, a limitation of our study was that we defined severe pelvic floor symptoms by setting the cut-off score at the 90 th percentile value of a randomly selected female population. No other cut-off score had been published before. Even though this might be considered a high value for dichotomization, the high prevalence of severe symptoms in each treatment group indicates that it is a defendable cut-off score. Strengths are that our study has a large number of included patients, a high response rate of 67% and a long follow-up of a median of 5 (PRT) and 6 (RH+LND and SART) years. By collecting a large variety of variables, we have gained insight into a range of factors associated with distress from pelvic floor symptoms in cervical cancer survivors. We did not correct for multiple testing, as we deliberately intended to explore associations between possible variables and severe pelvic floor symptoms and use these results for future prospective studies. Although none of the demographic and disease-related variables were multivariate significantly related to severe pelvic floor symptoms, the significant univariate associations are interesting and call for further interpretation. Smoking has a relation to severe urogenital (SART) or defecation (PRT) symptoms. Smoking is commonly thought to have a negative influence on urogenital symptoms, although the exact pathophysiology is not known. (27) Smoking is linked to urinary incontinence by increased abdominal pressure during coughing, and urgency and urgency incontinence might be explained by the effect of nicotine on increased detrusor activity. (28;29) In patients primarily treated with (chemo) radiotherapy more long term gastro-intestinal complications have been found in smokers. (30) The additional vasculotoxicity might be due to this relation, but immunological factors influenced by nicotine have also been mentioned to affect the bowels. (30) In PRT patients a higher BMI is associated with non-severe defecation symptoms. Eifel and coworkers found that thin women (BMI<22) had increased risk of gastrointestinal complications. (30) The dose reaching healthy organs, in this case the intestines will probably be much higher, than when fatty tissue surrounds the abdomen and the intra-abdominal organs.
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The only treatment-related variable significantly associated in univariate analysis was tumor diameter in RH+LND patients. Tumors between 1 and 4 cm were associated with non-severe defecation symptoms than tumor diameters of 1 cm and smaller. This finding is surprising, as logically, the larger the tumor the wider the parametrial excision and the more vaginal tissue has been excised. Clearly, larger excisions lead to more neural damage. It could be that women with larger tumors had more complaints before the surgical treatment than women with smaller tumors and therefore defecation symptoms might have been less negatively influenced by the treatment. However, this hypothesis should be studied in prospective research. Different hypotheses can be forwarded for the observed association between psychosocial factors and severe pelvic floor symptoms. Women with better mental and physical well-being may have more adequate coping strategies than women with poorer physical and mental well-being, and could therefore experience the pelvic floor symptoms as non-severe.(32) Severe distress from pelvic floor symptoms was found to be related to increased body image disturbance. Increased body image disturbance is a known result of cervical cancer treatment. (13) However, it could be that symptoms such as anal incontinence increase body image disturbance even more after cervical cancer treatment. Our findings can be used in counseling before treatment and during follow-up. In all treatment groups good physical functioning is associated with non-severe pelvic floor symptoms. Future studies should evaluate whether training programs, with both mental and physical aspects, would enhance the general well-being of cervical cancer patients and result in less distress related to present pelvic floor symptoms.
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